作者
Amanda L Trout, Michael P Kahle, Jill M Roberts, Aileen Marcelo, Leon de Hoog, Jeffery A Boychuk, Stephen L Grupke, Antonio Berretta, Emma K Gowing, Carie R Boychuk, Amanda A Gorman, Danielle N Edwards, Ibolya Rutkai, Ifechukwude J Biose, Hatsue Ishibashi-Ueda, Masafumi Ihara, Bret N Smith, Andrew N Clarkson, Gregory J Bix
发表日期
2021/2
期刊
Translational Stroke Research
卷号
12
页码范围
72-86
出版商
Springer US
简介
The extracellular matrix fragment perlecan domain V is neuroprotective and functionally restorative following experimental stroke. As neurogenesis is an important component of chronic post-stroke repair, and previous studies have implicated perlecan in developmental neurogenesis, we hypothesized that domain V could have a broad therapeutic window by enhancing neurogenesis after stroke. We demonstrated that domain V is chronically increased in the brains of human stroke patients, suggesting that it is present during post-stroke neurogenic periods. Furthermore, perlecan deficient mice had significantly less neuroblast precursor cells after experimental stroke. Seven-day delayed domain V administration enhanced neurogenesis and restored peri-infarct excitatory synaptic drive to neocortical layer 2/3 pyramidal neurons after experimental stroke. Domain V’s effects were inhibited by blockade of α2β1 …
引用总数
20202021202220232024366103
学术搜索中的文章
AL Trout, MP Kahle, JM Roberts, A Marcelo, L de Hoog… - Translational Stroke Research, 2021